ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Dana-Farber opens center for advanced cancer science.

April 23, 2004

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977

Hammer Signs $2.5 Mil. Check To NCI Fro Stop Cancer Campaign

February 2, 1990

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980